Quantitation of insulin-like growth factor-I and insulin-like growth factor-II with high-resolution mass spectrometry
Methods are provided for determining the amount of an IGF-I and/or IGF-II protein in a sample using high resolution/high accuracy mass spectrometry. The methods generally comprise enriching an IGF-I and/or IGF-II protein in a sample, ionizing an IGF-I and/or IGF-II protein from the sample to generate IGF-I and/or IGF-II protein ions, and determining the amount of IGF-I and/or IGF-II protein ions with high resolution/high accuracy mass spectrometry.
1. A method for determining the amount of an insulin-like growth factor-I (IGF-I) protein in a sample, the method comprising:
a. ionizing the sample to produce one or more ions detectable by mass spectrometry; and
b. determining the amount of one or more of the ions comprising an ion with a mass-to-charge ratio of 850.8±2 by high resolution/high accuracy time of flight (TOF) mass spectrometry; and
c. relating the amount of the determined ion or ions to the amount of IGF-I protein in the sample.
2. The method of claim 1 , wherein the method does not include digesting the protein prior to ionization.
3. The method of claim 1 , wherein the mass spectrometry is conducted with a mass analyzer capable of a full width at half maximum (FWHM) of greater than or equal to 10,000 and an accuracy of less than or equal to 50 ppm.
4. The method of claim 1 , wherein the method comprises determining the amount of an intact long R3 IGF-I.
5. The method of claim 1 , further comprising chemically modifying the protein, prior to ionization, to reduce the number of disulfide bridges in the protein.
6. The method of claim 1 , further comprising purifying the protein with solid phase extraction (SPE) prior to ionization.
7. The method of claim 1 , further comprising purifying the protein by high performance liquid chromatography (HPLC) prior to ionization.
8. The method of claim 1 , wherein with the mass analyzer is a time of flight mass analyzer capable of a FWHM of greater than or equal to 20,000 and an accuracy of less than or equal to 10 ppm.
9. The method of claim 1 , wherein the sample comprises plasma or serum.
10. The method of claim 1 , wherein the one or more ions detectable by mass spectrometry comprise one or more IGF-I ions in a 6+, 7+, 8+, or 9+ charge state.
11. The method of claim 1 , wherein the one or more ions used to determine the amount of the IGF-I protein further comprise one or more ions selected from the group of ions with a mass to charge ratio of 1091.9447±0.1, 1092.8031±0.1, 1092.9445±0.1, 1093.0881±0.1, 1093.2308±0.1, 1093.3740±0.1, 1093.5167±0.1, 1093.6597±0.1, 1093.8028±0.1, 1093.9458±0.1, 1094.0889±0.1, 1094.2319±0.1, 1094.3754±0.1, 1094.5185±0.1, 1094.6606±0.1, and 1095.3717±0.1.